Tags

Type your tag names separated by a space and hit enter

[Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease].
Gastroenterol Clin Biol. 2001 Sep; 25(2 Pt 2):C94-7.GC

Authors+Show Affiliations

Service d'Hépato-Gastroentérologie, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75908 Paris. philippe.marteau@egp.ap-hop-paris.frNo affiliation info available

Pub Type(s)

Comparative Study
Journal Article

Language

fre

PubMed ID

11787388

Citation

Marteau, P, and P Seksik. "[Role of Prebiotics and Probiotics in Therapeutic Management of Cryptogenetic Inflammatory Bowel Disease]." Gastroenterologie Clinique Et Biologique, vol. 25, no. 2 Pt 2, 2001, pp. C94-7.
Marteau P, Seksik P. [Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease]. Gastroenterol Clin Biol. 2001;25(2 Pt 2):C94-7.
Marteau, P., & Seksik, P. (2001). [Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease]. Gastroenterologie Clinique Et Biologique, 25(2 Pt 2), C94-7.
Marteau P, Seksik P. [Role of Prebiotics and Probiotics in Therapeutic Management of Cryptogenetic Inflammatory Bowel Disease]. Gastroenterol Clin Biol. 2001;25(2 Pt 2):C94-7. PubMed PMID: 11787388.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Role of prebiotics and probiotics in therapeutic management of cryptogenetic inflammatory bowel disease]. AU - Marteau,P, AU - Seksik,P, PY - 2002/1/15/pubmed PY - 2002/2/13/medline PY - 2002/1/15/entrez SP - C94 EP - 7 JF - Gastroenterologie clinique et biologique JO - Gastroenterol. Clin. Biol. VL - 25 IS - 2 Pt 2 SN - 0399-8320 UR - https://www.unboundmedicine.com/medline/citation/11787388/[Role_of_prebiotics_and_probiotics_in_therapeutic_management_of_cryptogenetic_inflammatory_bowel_disease]_ L2 - https://medlineplus.gov/crohnsdisease.html DB - PRIME DP - Unbound Medicine ER -